{"entity":{"id":"telehealth-oncology","kind":"technology","name":"Telehealth and hospital-at-home in oncology","aka":[],"tldr":"Video visits, remote monitoring and home delivery of some cancer treatments expanded massively during COVID-19 and have stayed; they reduce travel burden, especially for rural patients, without evidence of worse outcomes.","summary":"Telehealth use in oncology rose from ~1% to ~50% of visits at the 2020 peak and settled around 10-20%. Evidence: REACH PC (JAMA 2024) showed video palliative care equal to in-person; teleoncology models (Australia's Townsville, US rural networks) deliver chemotherapy supervision remotely; home infusion of some agents (subcutaneous daratumumab, pembrolizumab, trastuzumab-pertuzumab) and oral therapies with remote monitoring are growing; 'hospital-at-home' for febrile neutropenia and CAR-T monitoring is being piloted. Decentralised clinical trials use telehealth to broaden enrolment. Limits: broadband and digital literacy (the digital divide widens disparities), licensure across state lines, reimbursement parity, and the need for physical examination and imaging.","status":"established","asOf":"2026-09-08","wikipedia":"https://en.wikipedia.org/wiki/Telehealth","links":[{"label":"REACH PC (JAMA 2024)","url":"https://doi.org/10.1001/jama.2024.13964"},{"label":"ASCO telehealth standards 2021","url":"https://doi.org/10.1200/OP.21.00438"}],"tags":["gap-fill"],"related":[],"cancers":[],"sections":["ai-computation","supportive-care"],"technologies":["epro-symptom-monitoring","palliative-care","oncology-nursing","ai-trial-matching"],"targets":[],"drugs":[],"companies":["jasper-health","oncohealth","reimagine-care","thyme-care"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":["paper-zon-jco-oncol-pract","paper-greer-jama"],"journals":["jmir-cancer"],"dependsOn":[],"notes":[],"principle":"Substitute synchronous video or asynchronous digital contact and remote monitoring for in-person visits where physical assessment is not required, and move low-risk treatment and monitoring into the home.","strengths":["Reduces travel time and cost for patients","Equivalent outcomes for palliative care and follow-up visits","Expands trial and specialist access to rural areas"],"limitations":["Digital divide","Regulatory and reimbursement uncertainty","Not suitable for examination-dependent visits or complex toxicity"],"since":2020},"route":"/technologies/telehealth-oncology/","neighbours":{"section":[{"id":"ai-computation","kind":"section","name":"AI & Computation","route":"/fronts/ai-computation/"},{"id":"supportive-care","kind":"section","name":"Supportive Care & Survivorship","route":"/fronts/supportive-care/"}],"technology":[{"id":"rejuv-access-survivorship-care-australia","kind":"technology","name":"After treatment in Australia: a stated model of survivorship care","route":"/technologies/rejuv-access-survivorship-care-australia/"},{"id":"ai-trial-matching","kind":"technology","name":"AI trial matching & clinical decision support","route":"/technologies/ai-trial-matching/"},{"id":"rejuv-measure-epro-as-treatment","kind":"technology","name":"Asking people how they are, every week, as a treatment in its own right","route":"/technologies/rejuv-measure-epro-as-treatment/"},{"id":"palliative-care","kind":"technology","name":"Early integrated palliative care","route":"/technologies/palliative-care/"},{"id":"epro-symptom-monitoring","kind":"technology","name":"Electronic patient-reported outcome (ePRO) symptom monitoring","route":"/technologies/epro-symptom-monitoring/"},{"id":"financial-navigation","kind":"technology","name":"Financial toxicity and financial navigation","route":"/technologies/financial-navigation/"},{"id":"global-oncology-access","kind":"technology","name":"Global oncology and access in low- and middle-income countries","route":"/technologies/global-oncology-access/"},{"id":"multidisciplinary-tumour-board","kind":"technology","name":"Multidisciplinary tumour boards","route":"/technologies/multidisciplinary-tumour-board/"},{"id":"oncology-nursing","kind":"technology","name":"Oncology nursing and nurse-led care","route":"/technologies/oncology-nursing/"},{"id":"rejuv-measure-promis","kind":"technology","name":"PROMIS: the item banks that let a short questionnaire be precise","route":"/technologies/rejuv-measure-promis/"},{"id":"rejuv-measure-missing-data-and-who-is-not-asked","kind":"technology","name":"The questionnaires that were never returned, and the people never asked","route":"/technologies/rejuv-measure-missing-data-and-who-is-not-asked/"},{"id":"rejuv-measure-wearables-and-step-counts","kind":"technology","name":"Wearables and step counts: measuring what someone actually does","route":"/technologies/rejuv-measure-wearables-and-step-counts/"},{"id":"rejuv-measure-epro-implementation","kind":"technology","name":"What has actually been implemented since those trials, and what has not","route":"/technologies/rejuv-measure-epro-implementation/"},{"id":"rejuv-rehab-commissioning-inequity","kind":"technology","name":"Where rehabilitation is commissioned, and who misses out","route":"/technologies/rejuv-rehab-commissioning-inequity/"}],"company":[{"id":"jasper-health","kind":"company","name":"Jasper Health","route":"/companies/jasper-health/"},{"id":"oncohealth","kind":"company","name":"OncoHealth","route":"/companies/oncohealth/"},{"id":"reimagine-care","kind":"company","name":"Reimagine Care","route":"/companies/reimagine-care/"},{"id":"thyme-care","kind":"company","name":"Thyme Care","route":"/companies/thyme-care/"}],"paper":[{"id":"paper-zon-jco-oncol-pract","kind":"paper","name":"Telehealth in Oncology: ASCO Standards and Practice Recommendations","route":"/key-papers/paper-zon-jco-oncol-pract/"},{"id":"paper-greer-jama","kind":"paper","name":"Telehealth vs In-Person Early Palliative Care for Patients With Advanced Lung Cancer: A Multisite Randomized Clinical Trial","route":"/key-papers/paper-greer-jama/"}],"journal":[{"id":"jmir-cancer","kind":"journal","name":"JMIR cancer","route":"/journals/jmir-cancer/"}],"term":[{"id":"oncology-workforce","kind":"term","name":"Oncology workforce","route":"/terms/oncology-workforce/"}]}}